Assessment of wall thickness in hypertrophic cardiomyopathy (HCM) is of diagnostic and prognostic importance given its known association with sudden cardiac death. However, data regarding comparison of imaging modalities for this key measurement is lacking. This study seeks to compare assessment of maximum wall thickness between clinically indicated echocardiography (with and without contrast) and clinically indicated cardiac magnetic resonance imaging.
Patients receiving clinically indicated echocardiograms and cardiac magnetic resonance imaging at Mayo Clinic will be eligible.
Study Type
OBSERVATIONAL
Enrollment
110
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Left Ventricular Wall Thickness
All subjects will undergo noncontrast echocardiography, contrast echocardiography and cardiac MRI.
Time frame: approximately 1 week after enrollment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.